ESC 365 - Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: Why, when and for whom are they in line with the guidelines?

ESC Premium Access

Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: Why, when and for whom are they in line with the guidelines?

Session: Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: what is the rationale?

Topic: Treatment

Speaker: Doctor J. Wolf (Gdansk, PL)

Sponsored by Servier

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Jacek Wolf

Gdansk (Poland)

6 presentations

0 follower

2 more presentations in this session

Beta-blockers in hypertensive patients with comorbidities: where do we stand?

Speaker: Professor C. Maack (Wuerzburg, DE)

Discussion

Speaker: Professor C. Maack (Wuerzburg, DE) Doctor J. Wolf (Gdansk, PL) Professor K. Tsioufis (Athens, GR)

Access the full session

Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: what is the rationale?

Speakers: Doctor J. Wolf, Professor C. Maack, Professor C. Maack, Doctor J. Wolf, Professor K. Tsioufis

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources